First marketed in the United States in October 2015, Addyi has thus far failed to live up to the full potential that its developers and supporters believed it could have. However, a recent review of earlier clinical studies indicates that

Many women searching for a way to terminate an unwanted pregnancy are encountering obstacles that make it all but impossible to obtain such services through normal health care settings. In some countries, abortions are prohibited except in a few restricted

Widely touted as the long-awaited answer to demands for a medication to reinvigorate female sexual desire, Addyi has thus far proved to be a major disappointment. After a hard-fought battle for Food and Drug Administration approval, the prescription medication first

For years, the birth control pill has dominated the market, but recently the Ortho Evra patch has offered a new form of contraception.  The FDA approved the patch in 2001, but the product was criticized for its high risk of

The most common form of sexual dysfunction among women is a loss of desire for sex. Apart from its obvious effects on the sex lives of women suffering from low libido, this condition also poses a serious threat to the

The sharp contrast between the consumer reception for Viagra, the first of a wave of oral impotence medications, and that for Addyi, a drug designed to increase sexual desire in women, points up the stark differences between sexual dysfunction in